Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019096
Filing Date
2024-05-14
Accepted
2024-05-14 08:58:24
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 589681
2 form10-q_001.jpg GRAPHIC 4373
3 ex31-1.htm EX-31.1 20451
4 ex32-1.htm EX-32.1 8433
  Complete submission text file 0001493152-24-019096.txt   3781459

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gcan-20240331.xsd EX-101.SCH 30719
6 XBRL CALCULATION FILE gcan-20240331_cal.xml EX-101.CAL 31334
7 XBRL DEFINITION FILE gcan-20240331_def.xml EX-101.DEF 166965
8 XBRL LABEL FILE gcan-20240331_lab.xml EX-101.LAB 235155
9 XBRL PRESENTATION FILE gcan-20240331_pre.xml EX-101.PRE 208467
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 472258
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56027 | Film No.: 24941621
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)